Federica Grosso
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo · 348 works · 8,706 citations · h-index 46
Top works
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
- Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade
- Imatinib mesylate in chordoma
- Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
- Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- Myxoid/round cell and pleomorphic liposarcomas
- Real-time near-infrared (NIR) fluorescent cholangiography in single-site robotic cholecystectomy (SSRC): a single-institutional prospective study
- Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
- Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
- Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
- Single-site robotic cholecystectomy (SSRC) versus single-incision laparoscopic cholecystectomy (SILC): comparison of learning curves. First European experience
- A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas
- Extremity Soft Tissue Sarcoma: Adding to the Prognostic Meaning of Local Failure
- Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
- Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
- Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity
- Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma
- Mode of action of trabectedin in myxoid liposarcomas